EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of pimobendan on right-heart remodeling in dogs with tricuspid valve dysplasia: an exploratory study

Katie Abbott-Johnson, Brianna Potter, Lance Visser, Brian A. Scansen, Shiori Arai

Frontiers in Veterinary Science · 10.11.2026 · 13

DOI: 10.3389/fvets.2026.2003102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Veterinary Science, online erschienen am 10.11.2026. Verfasst von Katie Abbott-Johnson und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Tricuspid valve dysplasia (TVD) is a rare congenital heart defect in dogs often resulting in severe tricuspid valve regurgitation (TR). No guidelines for medical therapy have been established for dogs with severe TR. Tricuspid valve repair surgery is available for dogs but carries a moderate risk and high cost. This exploratory study evaluated the effect of oral pimobendan on chamber sizes and remodeling of the right side of the heart in dogs with TVD.

Methods

Retrospective echocardiographic data from ten dogs with TVD and severe TR were retrieved. All dogs received oral pimobendan (range 0.21–0.31 mg/kg Q12h) for an average of 18 months (range 3–41). The right atrial (RA) diameter, RA area, right ventricular (RV) diameter, RV area and fractional area change, tricuspid annular plane systolic excursion (TAPSE), and dimension of the tricuspid valve annulus (TVA) were quantified, and compared before and at a median of 3 months after starting pimobendan therapy.

Results

All dogs had severe TR. The normalized RV diameter and TVA decreased after pimobendan administration [1.40 → 1.27 (SD 0.23), p = 0.027; 11.77 → 10.58 (SD 1.95), p = 0.01]. No significant changes in RA area, RA diameter, RV area, TAPSE, peak TR velocity, or RV fractional area change were present after pimobendan therapy (all p > 0.08). No dogs in this study population progressed to right-sided congestive heart failure during the follow-up period. Conclusions and clinical importance Pimobendan reduced the size of the right ventricle and diameter of the tricuspid annulus compared to baseline, which may limit progression of disease in dogs with TVD with severe TR.

Zitieren

APA

Abbott-Johnson, K., Potter, B., Visser, L., Scansen, B. A., & Arai, S. (2026). Effect of pimobendan on right-heart remodeling in dogs with tricuspid valve dysplasia: an exploratory study. Frontiers in Veterinary Science, 13. https://doi.org/10.3389/fvets.2026.2003102

Vancouver

Abbott-Johnson K, Potter B, Visser L, Scansen BA, Arai S. Effect of pimobendan on right-heart remodeling in dogs with tricuspid valve dysplasia: an exploratory study. Frontiers in Veterinary Science. 2026;13. doi:10.3389/fvets.2026.2003102

BibTeX
@article{AbbottJohnson2026,
  author = {Abbott-Johnson, Katie and Potter, Brianna and Visser, Lance and Scansen, Brian A. and Arai, Shiori},
  title = {Effect of pimobendan on right-heart remodeling in dogs with tricuspid valve dysplasia: an exploratory study},
  journal = {Frontiers in Veterinary Science},
  year = {2026},
  volume = {13},
  doi = {10.3389/fvets.2026.2003102}
}
Kostenlos starten →